Literature DB >> 9706451

Diabetes mellitus and major depressive disorder: an overview of prevalence, complications, and treatment.

C Carney1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706451

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


× No keyword cloud information.
  5 in total

Review 1.  Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

Authors:  S M Cheer; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  A review of treating depression in diabetes: emerging findings.

Authors:  Sarah M Markowitz; Jeffrey S Gonzalez; Jesse L Wilkinson; Steven A Safren
Journal:  Psychosomatics       Date:  2011 Jan-Feb       Impact factor: 2.386

3.  The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care.

Authors:  Robert M. A. Hirschfeld
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-12

4.  Prevalence of depressive symptoms among non insulin treated Greek type 2 diabetic subjects.

Authors:  Alexios Sotiropoulos; Athanasia Papazafiropoulou; Ourania Apostolou; Anthi Kokolaki; Aristofanis Gikas; Stavros Pappas
Journal:  BMC Res Notes       Date:  2008-10-28

5.  Impact of an education program on patient anxiety, depression, glycemic control, and adherence to self-care and medication in Type 2 diabetes.

Authors:  Ayman A Al Hayek; Asirvatham A Robert; Mohamed A Al Dawish; Marwan M Zamzami; Asirvatham E Sam; Aus A Alzaid
Journal:  J Family Community Med       Date:  2013-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.